14 28
#Pharma #IndianPharma #Healthcare #Metformin #Diabetes #DrugDiscovery #PharmaceuticalIndustry #USV #SunPharma #AurobindoPharma #Lupin #Teva To view or add a comment, sign in GLP-1 impact: Jefferies sees these 3 stocks as winners in the race for Ozempic, Wegovy generics As several Indian pharma giants race to launch cheaper generics for Semaglutide, the active ingredient in popular weight-loss drugs Ozempic and Wegovy, international brokerage Jefferies said that Sun Pharma, Lupin and Torrent Pharma can emerge as the eventual winners.Novo Nordisks patent for GLP-1 (glucagon-like peptide-1) therapy expired last week
The platform facilitates access to virtual medical consultations and, where clinically appropriate, prescription medications through a streamlined online process with prescriptions shipped directly to patients' doors through licensed pharmacy partners
Whilst day-to-day hypoglycaemia was not coded in our network, we employed hypoglycaemia requiring hospital admission as a surrogate outcome of severe hypoglycaemia and there was no difference in the incidence in our cohort compared to the general population with type 1 diabetes
Similar to other GLP-1 medications, Saxenda may promote weight loss by reducing hunger cues and helping you to feel fuller and more satisfied after eating
